GenMont Biotech Incorporation (TPE:3164)
17.95
-0.05 (-0.28%)
Mar 24, 2026, 1:30 PM CST
-21.96% (1Y)
| Market Cap | 1.54B -12.5% |
| Revenue (ttm) | 401.23M +4.1% |
| Net Income | 57.20M -0.1% |
| EPS | 0.66 |
| Shares Out | 86.01M |
| PE Ratio | 27.20 |
| Forward PE | n/a |
| Dividend | 0.80 (4.44%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 44,993 |
| Average Volume | 75,367 |
| Open | 18.10 |
| Previous Close | 18.00 |
| Day's Range | 17.80 - 18.20 |
| 52-Week Range | 17.20 - 23.00 |
| Beta | 0.20 |
| RSI | 46.08 |
| Earnings Date | Mar 13, 2026 |